Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Gilley

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Trends in Molecular Medicine|March 9, 2007
Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connectionRobert Adalbert, Jonathan Gilley, Michael P Coleman
BMC Neuroscience|July 19, 2011
The MEK-ERK pathway negatively regulates bim expression through the 3' UTR in sympathetic neuronsRosie Hughes, Jonathan Gilley, Mark Kristiansen, et al.
Cell Reports|October 6, 2017
Sarm1 Deletion, but Not Wld<sup>S</sup>, Confers Lifelong Rescue in a Mouse Model of Severe AxonopathyJonathan Gilley, Richard R Ribchester, Michael P Coleman
Scientific Reports|August 16, 2022
Natural variants of human SARM1 cause both intrinsic and dominant loss-of-function influencing axon survivalMirlinda Ademi, Xiuna Yang, Michael P Coleman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 16, 2013
Rescue of peripheral and CNS axon defects in mice lacking NMNAT2Jonathan Gilley, Robert Adalbert, Gang Yu, et al.
Plos One|October 15, 2013
MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signalingCatherine Evans, Simon J Cook, Michael P Coleman, et al.
Cell Reports|March 31, 2015
Absence of SARM1 rescues development and survival of NMNAT2-deficient axonsJonathan Gilley, Giuseppe Orsomando, Isabel Nascimento-Ferreira, et al.
Human Molecular Genetics|October 11, 2018
Low levels of NMNAT2 compromise axon development and survivalJonathan Gilley, Paul R Mayer, Gang Yu, et al.
Neuroscience Research|January 19, 2023
NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapiesAndrea Loreto, Christina Antoniou, Elisa Merlini, et al.
Molecules (Basel, Switzerland)|February 24, 2024
Adaptation of a Commercial NAD<sup>+</sup> Quantification Kit to Assay the Base-Exchange Activity and Substrate Preferences of SARM1Ilenia Cirilli, Adolfo Amici, Jonathan Gilley, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Trends in Molecular Medicine|March 9, 2007
Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connectionRobert Adalbert, Jonathan Gilley, Michael P Coleman
BMC Neuroscience|July 19, 2011
The MEK-ERK pathway negatively regulates bim expression through the 3' UTR in sympathetic neuronsRosie Hughes, Jonathan Gilley, Mark Kristiansen, et al.
Cell Reports|October 6, 2017
Sarm1 Deletion, but Not Wld<sup>S</sup>, Confers Lifelong Rescue in a Mouse Model of Severe AxonopathyJonathan Gilley, Richard R Ribchester, Michael P Coleman
Scientific Reports|August 16, 2022
Natural variants of human SARM1 cause both intrinsic and dominant loss-of-function influencing axon survivalMirlinda Ademi, Xiuna Yang, Michael P Coleman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 16, 2013
Rescue of peripheral and CNS axon defects in mice lacking NMNAT2Jonathan Gilley, Robert Adalbert, Gang Yu, et al.
Plos One|October 15, 2013
MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signalingCatherine Evans, Simon J Cook, Michael P Coleman, et al.
Cell Reports|March 31, 2015
Absence of SARM1 rescues development and survival of NMNAT2-deficient axonsJonathan Gilley, Giuseppe Orsomando, Isabel Nascimento-Ferreira, et al.
Human Molecular Genetics|October 11, 2018
Low levels of NMNAT2 compromise axon development and survivalJonathan Gilley, Paul R Mayer, Gang Yu, et al.
Neuroscience Research|January 19, 2023
NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapiesAndrea Loreto, Christina Antoniou, Elisa Merlini, et al.
Molecules (Basel, Switzerland)|February 24, 2024
Adaptation of a Commercial NAD<sup>+</sup> Quantification Kit to Assay the Base-Exchange Activity and Substrate Preferences of SARM1Ilenia Cirilli, Adolfo Amici, Jonathan Gilley, et al.
Pageof 5